I never said it was price sensitive or otherwise.. It is business and likely price positive.
Two professionals with influence in exactly the place OCC needs to facilitate clinical take up and accordingly commercial uses of Remplir in the US.
You guys are arguing minutia, rather than focusing on the positives.
Ann: Leading US-based nerve surgeons appointed to advisory board, page-13
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.5¢ | $84.40K | 215.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 81519 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 78424 | 2 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |